Next month will be the 5 (FIVE) year anniversary from when Starpharma told investors via ASX announcement that one of the uses of funds from a capital raising would be for (and I quote):
‘DEP pipeline development to develop new DEP candidates to advance into clinical trials (e.g. antiviral, oncology &/or radiotherapeutic)’
Q: How many DEP candidates have advanced to clinical trials in the last (almost) 5 years (approx 1785 days)?
A: ZERO
Heads should have rolled.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $37.46K | 363.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 96813 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 45884 | 2 |
View Market Depth
| Last trade - 13.48pm 08/08/2025 (20 minute delay) ? |
| SPL (ASX) Chart |